Trademarkia Logo

Canada

C$
PILLS DESIGN (COLOUR)
ADVERTISED

on 8 Nov 2024

Last Applicant/ Owned by

MERCK SHARP & DOHME LLC

126 East Lincoln Ave.P.O. Box 2000Rahway, NJ 07065

US

Serial Number

2061401 filed on 2th Nov 2020

Registration Number

TMA1268192 registered on 8th Nov 2024

Registration expiry Date

8th Nov 2034

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

PILLS DESIGN (COLOUR)

Trademark usage description

pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the prevention and treatment of bone, c Read More

Vienna Information


19 . 13 . 1

Medical or surgical apparatus, instruments or utensils, prostheses, medicinesAppareils, instruments ou ustensiles de chirurgie ou de médecine, prothèses, médicaments

19 . 13 . 21

Phials, capsules, pills, tablets, suppositoriesAmpoules, capsules, pilules, tablettes, suppositoires

26 . 4 . 2

RectanglesRectangles

26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 6

Quadrilateral figures with one or more convex or concave sides -- Note: Not including elongated surfaces with one or more convex or concave sides (25.3.1).Figures quadrilatérales à un ou plusieurs côtés convexes ou concaves -- Note: Non compris les surfaces allongées avec un ou plusieurs côtés convexes ou concaves (25.3.1).

26 . 4 . 7

Two quadrilaterals, one inside the otherDeux quadrilatères, l'un dans l'autre

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 10

Quadrilaterals containing one or more circles, ellipses or polygonsQuadrilatères contenant un ou plusieurs cercles, ellipses ou polygones

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

25 . 3 . 1

Horizontally elongated surfacesSurfaces de forme allongée dans le sens horizontal

25 . 3 . 3

Elongated surfaces with two short sides convex or concaveSurfaces de forme allongée avec deux petits côtés convexes ou concaves

25 . 5 . 1

Backgrounds divided into two, verticallyFonds partagés en deux dans le sens vertical

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 4

BlueBleu

Classification Information


Class [005]
Pharmaceutical preparations and substances for use in Oncology; Pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gastrointestinal, musculoskeletal, nephrological, oncological, ophthalmic, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and dermatitis; Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations and substances for the prevention and treatment of genitourinary diseases and disorders, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations and substances for the prevention and treatment of gynecological diseases and disorders, namely amenorrhoea, dysmenorrheal and diseases and disorders relating to sexual reproduction and fertility; Pharmaceutical preparations and substances for the prevention and treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, arthritis, obesity and hypothyroidism; Pharmaceutical preparations and substances for the prevention and treatment of pain; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses and bipolar disorders; Pharmaceutical preparations and substances for the prevention and treatment of Respiratory Syncytial Virus (RSV); Pharmaceutical preparations substances for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, acne, rosacea, ichthyosis, urticaria and urinary incontinence; Pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-infectives, anti inflammatories, anti-parasitics, and antivirals; Human vaccine preparations; Inhaled pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2061401

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 21st Aug 2024
Advertised
Submitted for opposition 26
on 29th Jul 2024
Approved
Submitted for opposition 27
on 29th Jul 2024
Approval Notice Sent
Submitted for opposition 22
on 19th Jul 2024
Search Recorded
Submitted for opposition 48
on 15th Mar 2024
Agent Changed
Submitted for opposition 135
on 10th Aug 2022
Amendment to Application
Submitted for opposition 287
on 4th Aug 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 2th Nov 2020
Filed
Submitted for opposition 1
on 2th Nov 2020
Created
Submitted for opposition 31
on 2th Nov 2020
Formalized